June 20, 2025 – Prostate Cancer Patient Shares His Journey and more news…

Published: June 20, 2025

June 20, 2025

Essential Tremor Neuromodulation Clinical Trial Begins in California

Up to 60 participants will be enrolled in a clinical trial studying low-intensity focused ultrasound (LIFU) neuromodulation for treating essential tremor.
LIFU neuromodulation could be a useful tool for studying the brain circuits responsible for tremors and other brain disorders.

From Diagnosis to Hope: Bob’s Prostate Cancer Journey

Bob was diagnosed with prostate cancer in 2009, and just two weeks before his prostatectomy, he learned of TULSA (Transurethral Ultrasound Ablation).
The procedure uses directional ultrasound to produce very high temperatures to destroy targeted prostate tissue.

Read His Story

Podcast: Navigating Prostate Cancer Treated with Focused Ultrasound

In this episode, a prostate cancer patient is joined by a patient advocate from Profound Medical.
Learn more about the clinical benefits of the TULSA procedure and common patient concerns.

Listen to the Episode

First Commercial BPH Treatment with New AI-Assisted Technology

Profound Medical announced that the first patient was treated for benign prostatic hyperplasia (BPH) using the TULSA-PRO® system’s new TULSA-AI® Volume Reduction Module.
This software enhances procedural efficiency, decreases total treatment time, and allows for more personalized care.

Read the Press Release

HistoSonics’ Edison System Gains Early Market Access in Great Britain

The device has been granted early limited market access to treat patients with liver tumors using histotripsy through the UK’s Innovative Devices Access Pathway (IDAP).
The IDAP program helps fast-track transformative medical technologies to help patients for whom there are few options.

Read the Press Release

May 2025 Meeting Roundup

Eight recent conferences and webinars featured focused ultrasound presentations.

Read the Summaries

Breakthrough Devices Program: What Focused Ultrasound Companies Need to Know

This blog addresses the application process and benefits of the US Food and Drug Administration’s Breakthrough Devices Program.
To date, eight focused ultrasound companies have earned the designation.

Read the Post

Forwarded this email by a friend? Sign up to receive these emails here.

And Don't Miss

Submit Abstracts by August 14 | North American Neuromodulation Society (NANS) 2026

A Physician Explains Focused Ultrasound for the Prostate | Robotic HIFU Offers Noninvasive Option for Prostate Cancer

Focused Ultrasound for Diabetes and Inflammation | Doctors Could Hack the Nervous System With Ultrasound

See Recent News

Events

June 21-24, 2025 International Society for Therapeutic Ultrasound (ISTU) 24th International Symposium, Banff, Canada

June 21-22, 2025 Yangtze International Summit of Minimally Invasive and Noninvasive Medicine, Chongqing, China

June 30-July 4, 2025 International Symposium on Nonlinear Acoustics (ISNA), Nanjing, China

See All Upcoming Events

Do you have news for our newsletter? Tell us about it!

“I was in treatment for about an hour and a half and out that same afternoon. I even went to dinner with friends and family that night. Within 10 days, I was back in the gym and on vacation with my kids.”

‒ Bob Palmer, prostate cancer survivor

June 20, 2025 – Prostate Cancer Patient Shares His Journey and more news…

Contact

Terms of Use